CompletedNot Applicable

Osseodensification and Ridge Expansion for Implant Placement

Egypt5 participantsStarted 2022-04-01

Plain-language summary

Ridge expansion techniques allow implant placement in narrow alveolar ridges by increasing bone volume using the native bone. This technique has shown to be a safe and effective procedure.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Patients with partial edentulous alveolar ridges with adequate alveolar bone height and deficient width and density.
. Patients with good state of health and free from systemic or local pathosis that may influence the outcome of the therapy.
. Good oral hygiene.
. Age above 18 years.
. Agreement to participate in the study and also have to be able to attend postoperative clinical and radiological follow-up schedule.

Exclusion criteria

. Patients with para-functional habits such as bruxism and clenching or abnormal occlusal relationship that may complicate the future restoration.
. Patients with bad oral hygiene or smokers.
. Patients with uncontrolled systemic disease.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Title: Primary Implant Stability (ISQ Values)

Timeframe: Time Frame: At the time of implant placement (Day 0).

Trial details

NCT IDNCT07160309

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-01

View on ClinicalTrials.gov More Alveolar Bone Loss trials